ALBERTA IMMUNIZATION POLICY GUIDELINES

Size: px
Start display at page:

Download "ALBERTA IMMUNIZATION POLICY GUIDELINES"

Transcription

1 ALBERTA IMMUNIZATION POLICY GUIDELINES Diphtheria, Tetanus, Pertussis, Polio and Hib Vaccines. Diphtheria-Tetanus-Acellular Pertussis-Polio-Haemophilus influenzae type b Conjugate Combined Vaccine (DTaP-IPV- Hib) Please refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Name/Manufacturer INFANRIX -IPV/Hib 3 - GlaxoSmithKline Inc PEDIACEL - Sanofi Pasteur Indications for use of provincially funded vaccine Dose 0.5 ml Primary immunization of children months up to and including 59 months of age who need diphtheria, tetanus, acellular pertussis, polio and Hib vaccines. Children younger than 5 years of age who sustain a wound injury and have not received the recommended number of tetanus doses for their age and at least one dose of Hib vaccine at 5 months of age or older. Route Schedule Intramuscular injection (IM) Routine immunization for infants: Dose months Dose 4 months Dose 3 6 months Dose 4 8 months *If a dose is missed or delayed for any reason, the series does not have to be started again

2 General Contraindications Known severe allergy (anaphylaxis) to any component of the vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing diphtheria, tetanus, pertussis, polio or Hib. Some Possible Adverse Events Following Immunization Local reactions: Redness, swelling or tenderness at the injection site, generally mild and short-lasting. Persistent nodules at the site of injection may occur. Other reactions: Decreased activity, decreased appetite, fussiness, crying, fever, diarrhea and vomiting. References 3 National Advisory Committee on Immunization. (0. Canadian immunization guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. Retrieved from Sanofi Pasteur Limited. (0, April). PEDIACEL : Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed combined with inactivated poliomyelitis vaccine and Haemophilus b conjugate vaccine (tetanus Protein conjugate). Product Monograph. GlaxoSmithKline Inc. (0, August6). INFANRIX -IPV/Hib: Combined diphtheria,tetanus,acellualr pertussis vaccine, inactivated poliomyelitis and Haemophilus influenze type b vaccine. Product Monograph.

3 . Diphtheria-Tetanus-Acellular Pertussis-Polio Combined Vaccine (DTaP-IPV) Refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Name/Manufacturer BOOSTRIX -POLIO GlaxoSmithKline Inc. Indications for use of provincially funded vaccine Routine reinforcing dose for children between 4 and 6 years of age. Primary vaccine series or completion of a vaccine series for children 7 years of age up to 7 years of age. Wound management for children younger than 7 years of age. Refer to the Canadian Immunization Guide Guide to Tetanus Prophylaxis in Wound Management. Dose Route Schedule 0.5 ml Intramuscular injection (IM) Routine booster for children 4 to 6 years of age: One dose Unimmunized children 7 up to and including 7 years of age: Dose day 0 Dose 4 to 8 weeks after dose Dose 3 6 to months after dose 3

4 General Contraindications Known severe allergy (anaphylaxis) to any component of the vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing tetanus, diphtheria, pertussis or polio antigens. Some Possible Adverse Events Following Immunization Local reactions: Tenderness, redness and swelling at the injection site, generally mild and short-lasting. Severe local reactions occur rarely and may be associated with high levels of circulating tetanus antitoxin. Other reactions: Decreased activity, decreased eating, fussiness, crying, fever, diarrhea and vomiting. References National Advisory Committee on Immunization. (0. Canadian immunization guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. GlaxoSmithKline Inc. (0, July). BOOSTRIX -POLIO: Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactived poliomyelitis vaccine. Product Monograph. 4

5 3. Diphtheria-Tetanus-Acellular Pertussis Combined Vaccines (dtap) Refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Name/Manufacturer Indications for use of provincially funded vaccine Dose ADACEL - Sanofi Pasteur BOOSTRIX 3 - GlaxoSmithKline Inc. Children 7 years of age up to and including 7 years of age: With an uncertain or no history of a primary series or those who have not completed a primary series. Previously immunized against tetanus/diphtheria and due for a reinforcing dose of tetanus/diphtheria (routinely given to Grade 9 students in Alberta). Who sustain a wound. Notes: Diphtheria-tetanus-acellular pertussis combined vaccine is not usually provided to acute care emergency departments or urgent care centres. Children (7 to 7 years of age) needing tetanus prophylaxis for wound management should be referred to public health professionals for the age-appropriate tetanuscontaining vaccine. Not recommended for use in children younger than 7 years of age. Adults 8 years and older who are: Initiating (unknown/uncertain or no history of a primary series).¹ 0.5 ml Adults previously immunized against tetanus/diphtheria when they present for a reinforcing dose of tetanus/diphtheria. Health care workers who provide care to children younger than months of age. Some transplant candidates and recipients. 5

6 Route Schedule Intramuscular injection (IM) Series: Dose day 0 Dose 4 to 8 weeks after dose. Dose 3 6 to months after dose. Reinforcing dose: Grade 9 students or for wound management in children 7 to 7 years of age. Students who have received a dose of tetanusdiphtheria-acellular pertussis containing vaccine at years of age or older do not require the routine BOOSTRIX / ADACEL booster in Grade 9. General Contraindications Some Possible Adverse Events Following Immunization Known severe allergy (anaphylaxis) to any component of the vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing tetanus, diphtheria or Pertussis antigens. Local reactions: Pain, redness and swelling at the injection site, usually mild and short-lasting.,3 Severe local reactions occur rarely and may be associated with high levels of circulating tetanus antitoxin.,3 Other reactions: Dizziness, fever, headache, malaise, fatigue and vomiting.,3 References 3 National Advisory Committee on Immunization. (0) Canadian Immunization Guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. Sanofi Pasteur Limited. (0, June). ADACEL : Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed. Product Monograph. GlaxoSmithKline Inc. (03, Jan). BOOSTRIX : Combined diphtheria, tetanus, and acellular pertussis (adsorbed) vaccine for booster vaccination. Product Monograph. 6

7 4. Tetanus and Diphtheria Combined Vaccine (Td ADSORBED) Refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Name/Manufacturer Indications for use of provincially funded vaccine Dose Route Schedule Td ADSORBED - Sanofi Pasteur Individuals 8 years of age and older: Primary or reinforcing immunization. Wound management. Refer to the Canadian Immunization Guide Guide to Tetanus Prophylaxis in Wound Management. 0.5 ml Intramuscular injection(im) Primary vaccine series: Dose : day 0 Dose : 4 to 8 weeks after dose. Dose 3: 6 to months after dose. Note: Adults needing a primary series of tetanus/diphtheria vaccine should receive dtap to replace the first dose of Td in the series. Reinforcing doses are recommended at 0-year intervals. Note: For health care workers who provide care to children younger than months of age, and adults presenting for a tetanus-diphtheria booster, one reinforcing dose of tetanusdiphtheria-acellular pertussis containing vaccine is recommended in adulthood. General Contraindications Known severe allergy (anaphylaxis) to any component of the vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing tetanus or diphtheria antigens. 7

8 Some Possible Adverse Events Following Immunization Local reactions: Pain, swelling and redness at the injection site, usually short-lasting. Persistent nodules at the site of injection may occur. Following reinforcing doses, local redness and swelling are not uncommon. Systemic reactions: Fever, chills, and sore or swollen joints. References National Advisory Committee on Immunization. (0). Canadian immunization guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. Sanofi Pasteur Limited. (0, October). Td ADSORBED: Tetanus and diphtheria toxoids adsorbed. Product Monograph. 8

9 5. Haemophilus influenzae type b (Hib) Conjugate Vaccine Refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Name/Manufacturer Indications for use of provincially funded vaccine Dose Route Schedule Act-HIB - Sanofi Pasteur Limited HIBERIX ³ - GlaxoSmithKline Inc. Children months up to and including 59 months of age: Routinely given as part of combined vaccine (DTaP-IPV-Hib) Unimmunized individuals 5 years of age and older with specified chronic health conditions: Have no spleen (surgical removal) or severe dysfunction of the spleen. Hodgkin s disease. HIV. Cochlear implant recipients. Some transplant recipients. 0.5 ml Intramuscular injection (IM) Routine: Dose : months of age Dose : 4 months of age Dose 3: 6 months of age Dose 4: 8 months of age All doses in the routine schedule are administered as combined vaccine. Fewer doses are required for infants beginning immunization at seven months of age or older. Consult with your local public health service area for scheduling information. Older individuals with chronic health conditions: One dose 9

10 General Contraindications Known severe allergy (anaphylaxis) to any component of the vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing Hib antigens. Some Possible Adverse Local reactions: Events Following Immunization Pain, redness, swelling or induration at the injection site. Reactions generally occur early and are shortlasting. Systemic reactions: Fever, irritability, drowsiness, prolonged or abnormal crying, loss of appetite and vomiting have occurred after immunization. References National Advisory Committee on Immunization. (0). Canadian immunization guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. Sanofi Pasteur Limited. (0, May). Act-HIB : Haemophilus b conjugate vaccine (tetanus protein conjugate). Product Monograph. ³ GlaxoSmithKline Inc. (03, April). HIBERIX. Haemophilus influenzae type b conjugate vaccine (tetanus protein conjugate). Product Monograph 0

11 6. Polio Vaccine Refer to the vaccine product monograph and the Canadian Immunization Guide for further information. Product monographs are available on the Health Canada website: Trade Names/Manufacturers IMOVAX Polio (Vero Cell Origin) Sanofi Pasteur Indications for use of provincially funded vaccine Children 4 years of age and older who were previously immunized with diphtheria, pertussis or tetanus-containing vaccines only. Laboratory workers handling specimens that may contain poliovirus and who have not received polio immunization in the past. Health care workers and students training in health care occupations who have not received polio immunization in the past. Some transplant recipients Note: Polio vaccine is not recommended for routine immunization of adults living in Canada either as a primary series or reinforcing doses. Dose Route Schedule 0.5 ml Subcutaneous injection 4 years of age and older: Dose day 0 Dose 4 to 8 weeks after dose Dose 3 6 to months after dose Reinforcing doses are not necessary. Note: Although the IMOVAX Polio product is licensed for use in children of all ages, combination vaccines (e.g., DTaP- IPV-Hib and DTaP-IPV) are the products of choice for most infants and young children. Provincially funded IMOVAX Polio is provided for the indicated age group above. General Contraindications Known severe allergy (anaphylaxis) to any component of the poliomyelitis vaccine. Anaphylaxis or other severe allergic reaction to a previous dose of vaccine containing polio antigens.

12 Some Possible Adverse Events Following Immunization Local reactions: Redness, pain and swelling at the injection site, usually mild and transient in nature. Fever. References National Advisory Committee on Immunization. (0). Canadian immunization guide (Evergreen ed.). Ottawa, ON: Public Health Agency of Canada. Sanofi Pasteur Limited. (0, April). IMOVAX Polio: Inactivated poliomyelitis vaccine (Vero cell origin). Product Monograph.

ALBERTA IMMUNIZATION POLICY GUIDELINES

ALBERTA IMMUNIZATION POLICY GUIDELINES ALBERTA IMMUNIZATION POLICY GUIDELINES Hepatitis Vaccines. Hepatitis A Vaccines Refer to the vaccine product monograph and the Canadian Immunization Guide for further Product monographs are available on

More information

Appendix 7.5: Immunization for Children Expecting Solid Organ Transplant after 18 Months of Age (Catch-up and Ongoing Schedule)

Appendix 7.5: Immunization for Children Expecting Solid Organ Transplant after 18 Months of Age (Catch-up and Ongoing Schedule) Appendix 7.5: Immunization for Children Expecting Solid Organ Transplant after 18 Months of Age (Catch-up and Ongoing Schedule) Revision Date: September 5, 2014 Note: These guidelines are intended as a

More information

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240...

http://www.ilga.gov/commission/jcar/admincode/077/077006650b0240... 1 of 5 7/30/2014 9:47 AM TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER i: MATERNAL AND CHILD HEALTH PART 665 CHILD HEALTH EXAMINATION CODE SECTION 665.240 BASIC IMMUNIZATION

More information

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations VACCINE Table 1. Spanish Association of Paediatrics Immunisation Schedule. Recommendations of the Advisory Committee on Vaccines Age in months Age in years 0 2 4 6 12-15 15-18 2-3 4-6 11-12 Hepatitis B

More information

INDIVIDUAL VACCINE REQUIREMENTS SUMMARY. DIPHTHERIA, TETANUS, PERTUSSIS (DTaP, DT, Td, Tdap)

INDIVIDUAL VACCINE REQUIREMENTS SUMMARY. DIPHTHERIA, TETANUS, PERTUSSIS (DTaP, DT, Td, Tdap) DIPHTHERIA, TETANUS, PERTUSSIS (DTaP, DT, Td, Tdap) All students entering child care/preschool and kindergarten through 12 th grades must get vaccinated against diphtheria, tetanus, and pertussis. Routine

More information

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland

More information

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009

Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians. December 14, 2009 Vaccination Requirements for U.S. Immigration: Technical Instructions for Panel Physicians December 14, 2009 Table of Contents Preface... iii Significant Changes in the Vaccination Requirements... 1 Procedure

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale

More information

Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules

Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules Newfoundland and Labrador Immunization Manual Section 2 Routine Immunization Schedules Routine Immunization Schedules... 2.1-1 Policy on Routine Immunization Schedules... 2.1-2 Routine and Delayed Immunization

More information

Factsheet September 2012. Pertussis immunisation for pregnant women. Introduction

Factsheet September 2012. Pertussis immunisation for pregnant women. Introduction Factsheet September 2012 Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis.

More information

Pertussis (whooping cough) immunisation for pregnant women

Pertussis (whooping cough) immunisation for pregnant women Factsheet September 2012 Pertussis (whooping cough) immunisation for pregnant women Immunisation DEPARTMENT OF HEALTH Rheynn Slaynt The routine childhood immunisation programme has been very effective

More information

Pertussis (whooping cough) immunisation for pregnant women the safest way to protect yourself and your baby

Pertussis (whooping cough) immunisation for pregnant women the safest way to protect yourself and your baby Factsheet September 2012 Pertussis (whooping cough) immunisation for pregnant women the safest way to protect yourself and your baby The routine childhood immunisation programme has been very effective

More information

Chronology of vaccine use in New Brunswick Public Health programs*

Chronology of vaccine use in New Brunswick Public Health programs* Appendice 4.3 - History of Vaccine Use in New Brunswick 4.3.1 - History of Vaccine Use in New Brunswick - chronological listing Chronology of vaccine use in New Brunswick Public Health programs* * Please

More information

The clinical studies have been performed in children, adolescents and adults, from 4 years up to 55 years of age.

The clinical studies have been performed in children, adolescents and adults, from 4 years up to 55 years of age. NAME OF THE MEDICINE TdaP-Booster. Diphtheria, tetanus and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content). DESCRIPTION TdaP-Booster is a suspension for injection in pre-filled

More information

Immunization Information for Blinn College Students

Immunization Information for Blinn College Students 1 Immunization Information for Blinn College Students *Important Information Regarding the Bacterial Meningitis Vaccine* The State passed Senate Bill 1107 in 2011 and recently Senate Bill 62 in 2013, which

More information

Parents and Grandparents

Parents and Grandparents Parents and Grandparents Vaccination for parents and grandparents is vital to help protect newborn babies against whooping cough. Protect your baby by being immunised too. To find out more about Boostrix

More information

MEMO. Prevention Partnership Providers and Local Public Health Units. Vaccines for Children Coordinator. New Hib Vaccine Available

MEMO. Prevention Partnership Providers and Local Public Health Units. Vaccines for Children Coordinator. New Hib Vaccine Available MEMO TO: FROM: RE: Prevention Partnership Providers and Local Public Health Units Tatia Hardy Vaccines for Children Coordinator New Hib Vaccine Available DATE: October 12, 2009 The Food and Drug Administration

More information

Influenza virus Vaccine, Split Virus, When administered to individuals 3 years or older, for intramuscular use (Agriflu)

Influenza virus Vaccine, Split Virus, When administered to individuals 3 years or older, for intramuscular use (Agriflu) Adult Immunization Codes State and School Employees Life and Health Insurance Plan Not Subject to Calendar Year Deductible 100% of allowable for covered procedures Payable only for Network Providers (In-State

More information

Tdap booster vaccine for Health Care Workers Frequently Asked Questions for Health Professionals

Tdap booster vaccine for Health Care Workers Frequently Asked Questions for Health Professionals Tdap booster vaccine for Health Care Workers Frequently Asked Questions for Health Professionals NEW items in 2013 Immunisation Guidelines for Ireland are in RED What is Tdap booster vaccine? Tdap is a

More information

TdaP-Booster (tee-dee-ay-pee boo-ster)

TdaP-Booster (tee-dee-ay-pee boo-ster) New Zealand Consumer Medicine Information TdaP-Booster (tee-dee-ay-pee boo-ster) Tetanus, diphtheria and pertussis (acellular mono-component) vaccine (adsorbed, reduced antigen content) CONSUMER MEDICINE

More information

Anthrax vaccine side-effects

Anthrax vaccine side-effects Anthrax vaccine side-effects What are the risks from anthrax vaccine? Like any medicine, a vaccine could cause a serious problem, such as a severe allergic reaction. Anthrax is a very serious disease,

More information

The Challenge of Whooping Cough:

The Challenge of Whooping Cough: The Challenge of Whooping Cough: Canada s Role in the Development of Pertussis Vaccines AUTHORS: Luis Barreto, M.B.B.S., M.D., M.H.Sc. Rob Van Exan, Ph.D. Christopher Rutty, Ph.D. CREATED THROUGH AN EDUCATIONAL

More information

Whooping Cough Vaccine for Pregnant Women

Whooping Cough Vaccine for Pregnant Women Whooping Cough Vaccine for Pregnant Women What is whooping cough (pertussis)? Whooping cough (also known as pertussis) is a highly contagious illness that can be life threatening. The disease is most serious

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS Registration No. : 2C 22/47 (N) Importer / Manufacturer: Sanofi Pasteur Ltd., Thailand/Sanofi Pasteur S.A., France SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT : PENTAXIM (Diphtheria,

More information

Prevention of Pertussis Among Pregnant & Post Partum Women and Their Infants. Marilyn Michels RN MSN CIC Kathleen Curtis MS RN

Prevention of Pertussis Among Pregnant & Post Partum Women and Their Infants. Marilyn Michels RN MSN CIC Kathleen Curtis MS RN Prevention of Pertussis Among Pregnant & Post Partum Women and Their Infants Marilyn Michels RN MSN CIC Kathleen Curtis MS RN Pertussis and Adults Pertussis (whooping cough) a poorly controlled vaccine-preventable

More information

Hepatitis A Vaccine Biological Page

Hepatitis A Vaccine Biological Page Hepatitis A Vaccine Biological Page Section 7: Biological Product Information Standard #: 07.230 Created by: Province-wide Immunization Program Standards and Quality Approved by: Province-wide Immunization

More information

Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2014

Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2014 Recommended Immunization Schedules for Persons Aged 0 Through 18 Years UNITED STATES, 2014 This schedule includes recommendations in effect as of January 1, 2014. Any dose not administered at the recommended

More information

CALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4

CALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4 CALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4 Subchapter 8. Immunization Against Poliomyelitis, Diphtheria, Pertussis, Tetanus, Measles (Rubeola), Article 1. Definitions Haemophilus influenzae

More information

General Colorado Immunization Guidelines... 3. Varicella (Chickenpox) Disease and Varicella Vaccine... 4. DTaP/Tdap/Td Vaccines...

General Colorado Immunization Guidelines... 3. Varicella (Chickenpox) Disease and Varicella Vaccine... 4. DTaP/Tdap/Td Vaccines... General Colorado Immunization Guidelines... 3 What is the difference between Colorado school required immunizations and immunizations that are recommended?... 3 What is the 4 day grace period for vaccines

More information

Is your family at risk for pertussis?

Is your family at risk for pertussis? Is your family at risk for pertussis? Help protect your family against a serious disease and talk to your health-care professional about adult and adolescent immunization with Adacel vaccine. Please click

More information

TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN

TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN TEMPORARY PROGRAMME PERTUSSIS VACCINATION FOR PREGNANT WOMEN Richard Smithson Neil Irvine Maureen McCartney Consultant Health Protection October 2012 Pertussis/whooping cough The disease Whooping Cough

More information

Resource Document 6: Tetanus Immunization. I. Introduction

Resource Document 6: Tetanus Immunization. I. Introduction Resource Document 6: Tetanus Immunization I. Introduction Attention must be directed to adequate tetanus prophylaxis in the multiply injured patient, particularly if open-extremity trauma is present. The

More information

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH)

FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) FREQUENTLY ASKED QUESTIONS ABOUT PERTUSSIS (WHOOPING COUGH) What is pertussis? General Questions About Pertussis Pertussis, or whooping cough, is a contagious illness that is spread when an infected person

More information

Guidelines for Vaccinating Pregnant Women

Guidelines for Vaccinating Pregnant Women Guidelines for Vaccinating Pregnant Women U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control & Prevention Guidelines for Vaccinating Pregnant Women from Recommendations of the Advisory

More information

DENMARK S CHILDHOOD VACCINATION PROGRAMME

DENMARK S CHILDHOOD VACCINATION PROGRAMME DENMARK S CHILDHOOD VACCINATION PROGRAMME 2013 7th EDITION Denmark s childhood vaccination programme, 2012 7th edition 2013 by the Danish Health and Medicines Authority. All rights reserved. Danish Health

More information

See 17 for PATIENT COUNSELING INFORMATION. Revised: XX/XXXX

See 17 for PATIENT COUNSELING INFORMATION. Revised: XX/XXXX HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus

More information

Vaccinations and Spina Bifida and Hydrocephalus

Vaccinations and Spina Bifida and Hydrocephalus shinecharity.org.uk info@shinecharity.org.uk 42 Park Road Peterborough PE1 2UQ 01733 555988 Vaccinations and Spina Bifida and Hydrocephalus Vaccines are made from parts of bacteria or viruses that cause

More information

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme

Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme Change to DENMARK S CHILDHOOD VACCINATION PROGRAMME 2014 Addition of vaccination against hepatitis B infection and change of the HPV vaccination programme 2014 Addition to the Danish Health and Medicines

More information

Vaccination against pertussis (Whooping cough) for pregnant women- 2014. Information for healthcare professionals

Vaccination against pertussis (Whooping cough) for pregnant women- 2014. Information for healthcare professionals Vaccination against pertussis (Whooping cough) for pregnant women- 2014 Information for healthcare professionals About Public Health England Public Health England s mission is to protect and improve the

More information

Chapter 3. Immunity and how vaccines work

Chapter 3. Immunity and how vaccines work Chapter 3 Immunity and how vaccines work 3.1 Objectives: To understand and describe the immune system and how vaccines produce immunity To understand the differences between Passive and Active immunity

More information

Immunization Healthcare Branch. Meningococcal Vaccination Program Questions and Answers. Prepared by

Immunization Healthcare Branch. Meningococcal Vaccination Program Questions and Answers. Prepared by Immunization Healthcare Branch Meningococcal Vaccination Program Questions and Answers Prepared by Immunization Healthcare Branch (IHB), Defense Health Agency Last Updated: 27 Mar 06 www.vaccines.mil 877-GET-VACC

More information

Coding for Vaccines and Immunization Administration in 2011: Major and Welcome Changes to the CPT 2011 Immunization Administration Codes

Coding for Vaccines and Immunization Administration in 2011: Major and Welcome Changes to the CPT 2011 Immunization Administration Codes Page 1 of 9 Print Close Window Coding for Vaccines and Immunization Administration in 2011: Major and Welcome Changes to the CPT 2011 Immunization Administration Codes November 2010 Pediatricians and pediatric

More information

Immunization FAQs Required Vaccines for 2014-15 School Year

Immunization FAQs Required Vaccines for 2014-15 School Year Immunization Schedules and Documentation Immunization FAQs Required Vaccines for 2014-15 School Year 1. Question: What is the difference between the recommended immunization schedule and the Colorado School

More information

LOEWENBERG SCHOOL OF NURSING LOEWENBERG SCHOOL OF NURSING HEALTH EXAMINATION FORM (FORM 003)

LOEWENBERG SCHOOL OF NURSING LOEWENBERG SCHOOL OF NURSING HEALTH EXAMINATION FORM (FORM 003) SECTION I: To be completed by STUDENT: Name: DOB: Address: Phone (H): Phone (C): Health History: Please complete the following information: Recent weight loss or gain Fatigue, fever, sweats Difficulty

More information

Updated Recommendations for Use of Tdap in Pregnant Women

Updated Recommendations for Use of Tdap in Pregnant Women From the Texas Department of State Health Services Immunization Branch The goal of the Vaccine Advisory is to disseminate, in a timely manner, practical information related to vaccines, vaccine-preventable

More information

WellCare Clinical Practice Guidance - A Review

WellCare Clinical Practice Guidance - A Review Copyright 2008 by the American Academy of Pediatrics. Please see the following link for additional information concerning the AAP recommendations. http://brightfutures.aap.org/ Reference: American Academy

More information

Childhood. Immunisation

Childhood. Immunisation Childhood Immunisation Contents Introduction................................................................. 1 What is immunisation?........................................................ 2 What is a

More information

PRODUCT MONOGRAPH INFANRIX -IPV. Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine

PRODUCT MONOGRAPH INFANRIX -IPV. Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine PRODUCT MONOGRAPH INFANRIX -IPV Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine Sterile suspension for injection Single dose pre-filled syringe Active immunizing

More information

Immunization Frequently Asked Questions for K-12 th Grades 2015-2016 Colorado School Required Immunizations

Immunization Frequently Asked Questions for K-12 th Grades 2015-2016 Colorado School Required Immunizations Immunization Frequently Asked Questions for K-12 th Grades 2015-2016 Colorado School Required Immunizations General Colorado Immunization Guidelines... 3 What does is mean for a school to be in compliance

More information

Frequently Asked Questions for the Pediatric Immunization Administration Codes

Frequently Asked Questions for the Pediatric Immunization Administration Codes Frequently Asked Questions for the Pediatric Immunization Administration Codes Component Definition Old versus New IA Codes Counseling and OQHCP Documentation Requirements When to still report 90471-90474

More information

The Immunization Office, located in the Student Health Center, is open year round to administer needed immunizations at a nominal fee.

The Immunization Office, located in the Student Health Center, is open year round to administer needed immunizations at a nominal fee. Student Health Services 2815 Cates Avenue Raleigh, NC 27695-7304 919-515-2563 healthcenter.ncsu.edu The Immunization Record Form is designed to collect information about your current immunization status.

More information

ILLINOIS REGISTER DEPARTMENT OF PUBLIC HEALTH NOTICE OF ADOPTED AMENDMENTS

ILLINOIS REGISTER DEPARTMENT OF PUBLIC HEALTH NOTICE OF ADOPTED AMENDMENTS 1) Heading of the Part: Immunization Code 2) Code Citation: 77 Ill. Adm. Code 695 3) Section Numbers: Adopted Action: 669.5 New 695.7 New 695.10 Amended 695.20 Amended 695.30 Amended 695.40 Amended 695.50

More information

TEXAS ADMINISTRATIVE CODE

TEXAS ADMINISTRATIVE CODE TEXAS ADMINISTRATIVE CODE TITLE 25 PART 1 CHAPTER 97 SUBCHAPTER B HEALTH SERVICES DEPARTMENT OF STATE HEALTH SERVICES COMMUNICABLE DISEASES IMMUNIZATION REQUIREMENTS IN TEXAS ELEMENTARY AND SECONDARY SCHOOLS

More information

See 17 for PATIENT COUNSELING INFORMATION. Revised: 07/2012

See 17 for PATIENT COUNSELING INFORMATION. Revised: 07/2012 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INFANRIX safely and effectively. See full prescribing information for INFANRIX. INFANRIX (Diphtheria

More information

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals

MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals What is Bexsero vaccine? Bexsero is a meningococcal Group B (MenB) vaccine which is indicated for the active immunisation of

More information

APPENDIX EE VACCINE STATUS AND DATE

APPENDIX EE VACCINE STATUS AND DATE VACCINE STATUS AND DATE Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells the vaccine

More information

THE DANISH CHILDHOOD VACCINATION PROGRAMME

THE DANISH CHILDHOOD VACCINATION PROGRAMME THE DANISH CHILDHOOD VACCINATION PROGRAMME 2015 CONTENTS Introduction 2 The Danish childhood vaccination programme 3 Why do we vaccinate children in Denmark? 4 The diseases 5 Diphtheria 5 Tetanus 5 Whooping

More information

Pre-school immunisations

Pre-school immunisations Pre-school immunisations A guide to vaccinations at three years and four months of age the safest way to protect your child The complete routine childhood immunisation programme These booklets describe

More information

Questions and Answers on Immunization Regulations Pertaining to Children Attending School/ Higher Education

Questions and Answers on Immunization Regulations Pertaining to Children Attending School/ Higher Education New Jersey Department of Health (NJDOH), Vaccine Preventable Disease Program Questions and Answers on Immunization Regulations Pertaining to Children Attending School/ Higher Education Frequently Asked

More information

Document Title: PCT Doc Ref.: Version No.: 1/2014. Local Doc Ref.:

Document Title: PCT Doc Ref.: Version No.: 1/2014. Local Doc Ref.: Document Title: Patient Group Direction (PGD) for the vaccination of pregnant women (gestation week 28 onwards) and new mothers against pertussis (Whooping Cough) using Boostrix-IPV (Diphtheria, tetanus,

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT Safety of HPV vaccination: A FIGO STATEMENT July, 2013 Human papillomavirus vaccines are used in many countries; globally, more than 175 million doses have been distributed. Extensive pre- and post-licensure

More information

This article is a CME/CE certified activity. To earn credit for this activity visit: http://www.medscape.org/viewarticle/750546

This article is a CME/CE certified activity. To earn credit for this activity visit: http://www.medscape.org/viewarticle/750546 1 of 6 10/10/2011 7:17 PM This article is a CME/CE certified activity. To earn credit for this activity visit: http://www.medscape.org/viewarticle/750546 CME/CE Information CME/CE Released: 09/28/2011;

More information

2 P age. Babies from Birth to Age 2

2 P age. Babies from Birth to Age 2 Contents Babies from Birth to Age 2... 2 Vaccines give parents the power... 2 Vaccines are recommended throughout our lives... 3 Talk to your doctor... 3 Vaccines are very safe... 3 Whooping Cough (Pertussis)...

More information

Vaccine Administration Record for Adults

Vaccine Administration Record for Adults (Page 1 of 2) Administration Record for Adults Birthdate: Before administering any vaccines, give the patient copies of all pertinent Information Statements (VISs) and make sure he/she understands the

More information

HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular Injection Initial U.S.

HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] Solution for Intramuscular Injection Initial U.S. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX. HIBERIX [Haemophilus

More information

Why Pertussis matters..

Why Pertussis matters.. Why Pertussis matters.. Pertussis (Whooping cough) outbreaks continue to impact children & adults, both locally and across the US. Cases have been on the rise since the 1980 s. However, recent data on

More information

From: Michael P. Schmitt, Ph. D. Laboratory of Respiratory and Special Pathogens, Division of Bacterial, Parasitic, and Allergenic Products, HFM-437

From: Michael P. Schmitt, Ph. D. Laboratory of Respiratory and Special Pathogens, Division of Bacterial, Parasitic, and Allergenic Products, HFM-437 DEPARTMENT OF HEALTH & HUMAN SERVICES FDA, Center for Biologics Evaluation and Research MEMORANDUM Date: December 21,2007 From: Michael P. Schmitt, Ph. D. Laboratory of Respiratory and Special Pathogens,

More information

PRIMARY CARE PRACTICE GUIDELINES

PRIMARY CARE PRACTICE GUIDELINES 1 of 6 1. OUTCOME To identify anaphylaxis in the primary care setting and provide an evidence informed emergency response utilizing the most current provincial and federal practice guidelines. 2. DEFINITIONS

More information

Provider Billing Communication Health Check Services (EPSDT)

Provider Billing Communication Health Check Services (EPSDT) Provider Billing Communication Health Check Services (SDT) All preventive or well-child services, except normal newborn care in the hospital, must be billed under the Health Check program following the

More information

Pertussis. Bordetella pertussis. Pathogenesis. Clinical Features

Pertussis. Bordetella pertussis. Pathogenesis. Clinical Features Pertussis, or whooping cough, is an acute infectious disease caused by the bacterium Bordetella pertussis. Outbreaks of pertussis were first described in the th century, and the organism was first isolated

More information

Pertussis. History and epidemiology of the disease. The disease. Pertussis

Pertussis. History and epidemiology of the disease. The disease. Pertussis 24 The disease NOTIFIABLE Whooping cough (pertussis) is a highly infectious disease that is usually caused by Bordetella pertussis. A similar illness is caused by B. parapertussis, but this is not preventable

More information

Remove this cover sheet before redistributing and replace it with your own. Please ensure that DPHHS is included on your HAN distribution list.

Remove this cover sheet before redistributing and replace it with your own. Please ensure that DPHHS is included on your HAN distribution list. State of Montana Health Alert Network DPHHS HAN ADVISORY Cover Sheet DATE: May 15, 2012 SUBJECT: Pertussis INSTRUCTIONS: DISTRIBUTE to your local HAN contacts. This HAN is intended for general sharing

More information

Tdap and MenC booster vaccines. Information for parents of children in First Year of second level school

Tdap and MenC booster vaccines. Information for parents of children in First Year of second level school Tdap and MenC booster vaccines Information for parents of children in First Year of second level school Tdap and MenC booster vaccines Information for parents of children in First Year of second level

More information

Vaccines for a Healthy Pregnancy

Vaccines for a Healthy Pregnancy Vaccines for a Healthy Pregnancy Vaccines for a Healthy Pregnancy G ALLERY I.1 Healthy Mother and Baby I II Introduction to Tutorial About Flu and Whooping Cough III Getting Vaccinated During Pregnancy:

More information

Health Check Billing Guide for Providers

Health Check Billing Guide for Providers Health Check Billing Guide for Providers All preventive or well-child services except normal newborn care in the hospital must be billed under the Health Check program following the policies and procedures

More information

What You Need to Know About the National Vaccine Injury Compensation Program (VICP)

What You Need to Know About the National Vaccine Injury Compensation Program (VICP) What You Need to Know About the National Vaccine Injury Compensation Program (VICP) NOTE: What You Need to Know About the National Vaccine Injury Compensation Program (VICP) is not a legal document. The

More information

Regulations of Connecticut State Agencies. R.C.S.A. 10-204a-1 10-204a-4 CONTENTS. Procedures for reporting immunization data

Regulations of Connecticut State Agencies. R.C.S.A. 10-204a-1 10-204a-4 CONTENTS. Procedures for reporting immunization data Agency Subject School Immunizations Requirements Inclusive Sections 10-204a-1 10-204a-4 Sec. 10-204a-1. Sec. 10-204a-2. Sec. 10-204a-2a. Sec. 10-204a-3. Sec. 10-204a-3a. Sec. 10-204a-4. CONTENTS Definitions

More information

--------------RECENT MAJOR CHANGES--------------------- INDICATIONS AND USAGE (1) 8/2013 DOSAGE AND ADMINISTRATION (2) Dosing Schedule (2.

--------------RECENT MAJOR CHANGES--------------------- INDICATIONS AND USAGE (1) 8/2013 DOSAGE AND ADMINISTRATION (2) Dosing Schedule (2. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. [Meningococcal (Groups A, C, Y and

More information

New Jersey Department of Health Vaccine Preventable Disease Program Pertussis FAQs. Date: January 10, 2013

New Jersey Department of Health Vaccine Preventable Disease Program Pertussis FAQs. Date: January 10, 2013 New Jersey Department of Health Vaccine Preventable Disease Program Pertussis FAQs Date: January 10, 2013 KEY MESSAGES: 1. Pertussis is a very contagious vaccine-preventable disease that can cause serious

More information

ARKANSAS DEPARTMENT OF EDUCATION RULES GOVERNING KINDERGARTEN THROUGH 12 TH GRADE IMMUNIZATION REQUIREMENTS IN ARKANSAS PUBLIC SCHOOLS May 2010

ARKANSAS DEPARTMENT OF EDUCATION RULES GOVERNING KINDERGARTEN THROUGH 12 TH GRADE IMMUNIZATION REQUIREMENTS IN ARKANSAS PUBLIC SCHOOLS May 2010 ARKANSAS DEPARTMENT OF EDUCATION RULES GOVERNING KINDERGARTEN THROUGH 12 TH GRADE IMMUNIZATION REQUIREMENTS IN ARKANSAS PUBLIC SCHOOLS May 2010 1.0 PURPOSE 1.01 The purpose of these rules is to establish

More information

Vaccination (Immunization)

Vaccination (Immunization) Policy Number IMM10012009SC Approved By Vaccination (Immunization) UnitedHealthcare Medicare Committee Current Approval Date 04/08/2015 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Infanrix -IPV+Hib (as logo) vaccine Powder and suspension for suspension for injection Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated)

More information

Polio and the Introduction of IPV

Polio and the Introduction of IPV Polio and the Introduction of IPV Poliomyelitis (polio) is a highly infectious disease that is caused when a person is infected by the polio virus that invades the nervous system. Poliomyelitis can cause

More information

FAQs on Influenza A (H1N1-2009) Vaccine

FAQs on Influenza A (H1N1-2009) Vaccine FAQs on Influenza A (H1N1-2009) Vaccine 1) What is Influenza A (H1N1-2009) (swine flu) 1? Influenza A (H1N1-2009), previously known as "swine flu", is a new strain of influenza virus that spreads from

More information

Plan early - get your vaccinations in time for full protection. To prepare for your trip, schedule an appointment: (910) 347-2154, option #2.

Plan early - get your vaccinations in time for full protection. To prepare for your trip, schedule an appointment: (910) 347-2154, option #2. The Onslow County Health Department Travel Clinic offers a complete line of immunizations and prescriptions to protect you while traveling abroad. The most appropriate immunizations and travel medications

More information

Transient Hypogammaglobulinemia of Infancy. Chapter 7

Transient Hypogammaglobulinemia of Infancy. Chapter 7 Transient Hypogammaglobulinemia of Infancy Chapter 7 An unborn baby makes no IgG (antibody) and only slowly starts producing it after birth. However, starting at about the sixth month of pregnancy, the

More information

New Jersey Immunization Requirements

New Jersey Immunization Requirements New Jersey Immunization Requirements Jenish Sudhakaran, MPH Jennifer Smith, MPH, CHES Vaccine Preventable Disease Program NJ Department of Health & Senior Services March 2012 Purpose of N.J.A.C. 8:57-4

More information

99381, 99382: Initial preventive medicine evaluation 99391, 99392: Periodic preventive medicine re-evaluation

99381, 99382: Initial preventive medicine evaluation 99391, 99392: Periodic preventive medicine re-evaluation Age Birth - 24 months 2-11 s M/ M/ Preventive medicine, re-, or office visit/ 8 visits within the first 24 months of life (As part of preventive medicine or re-, Hemoglobin, hematocrit, or CBC for those

More information

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo REVISED : OCTOBER 2010 This document was published by: The National Department of Health Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo Copies may be obtained from: The National Department

More information

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013.

The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013. The format of this leaflet was determined by the Ministry of Health and its content was checked and approved in May 2013 Havrix 720 Junior 1 NAME OF THE MEDICINAL PRODUCT Havrix 720 Junior 2 QUALITATIVE

More information

Adult Vaccination Frequently Asked Questions: The Basics

Adult Vaccination Frequently Asked Questions: The Basics The Basics Why should I get vaccinated? Vaccination is the best way to protect against infections that can make you sick and be passed on to those around you. 1 What kinds of side effects will I get from

More information

RABIES PROPHYLAXIS OF PEOPLE

RABIES PROPHYLAXIS OF PEOPLE RABIES PROPHYLAXIS OF PEOPLE Persons can be protected against rabies through a vaccine -- the vaccine which is currently being used is Rabies Human Diploid Cell Vaccine (HDCV). The preexposure series can

More information

Vaccination of children and adolescents

Vaccination of children and adolescents Information letter from the Norwegian Institute of Public Health No. 3 National childhood vaccination programme in Norway English Last updated July 2010 www.fhi.no/publ/infoletter Vaccination of children

More information

NWX-DISEASE CONTROL & PREVENTI. Moderator: Dale Babcock. September 2, 2015 11:00 am CT

NWX-DISEASE CONTROL & PREVENTI. Moderator: Dale Babcock. September 2, 2015 11:00 am CT Page 1 NWX-DISEASE CONTROL & PREVENTI September 2, 2015 11:00 am CT Coordinator: Welcome and thank you for standing by. At this time all participants are in a listen-only mode. During the Q&A session if

More information

University of Virginia Elson Department of Student Health PO Box 800760 Charlottesville VA 22908 434-982-3915 ADACEL. (Tdap)

University of Virginia Elson Department of Student Health PO Box 800760 Charlottesville VA 22908 434-982-3915 ADACEL. (Tdap) ADACEL (Tdap) Diphtheria, tetanus and pertussis are serious diseases caused by bacteria. With diphtheria, a membrane grows which can cover the tonsils and throat. Pertussis is a highly contagious respiratory

More information

Summary of the risk management plan (RMP) for Tritanrix HB [Diphtheria, tetanus, pertussis (whole cell) and hepatitis B (rdna) vaccine (adsorbed)]

Summary of the risk management plan (RMP) for Tritanrix HB [Diphtheria, tetanus, pertussis (whole cell) and hepatitis B (rdna) vaccine (adsorbed)] EMA/14365/2014 Summary of the risk management plan (RMP) for Tritanrix HB [Diphtheria, tetanus, pertussis (whole cell) and hepatitis B (rdna) vaccine (adsorbed)] Overview of disease epidemiology Diphtheria

More information

University of Alberta 2015-2016 Faculty Immunization Clearance Form: Requirements for Validating Forms for Entry into a Program

University of Alberta 2015-2016 Faculty Immunization Clearance Form: Requirements for Validating Forms for Entry into a Program University of Alberta 2015-2016 Faculty Immunization Clearance Form: Requirements for Validating Forms for Entry into a Program Key Terms & Abbreviations: dtap: tetanus, diphtheria, acellular pertussis

More information

Anaphylaxis and other adverse events

Anaphylaxis and other adverse events Anaphylaxis and other adverse events Aim: To be able to manage anaphylaxis and other adverse events correctly Learning outcomes Define local and systemic adverse events Distinguish between anaphylaxis

More information

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination

2 months Diptheria; Tetanus; Whooping Cough; Hib & Polio 1st dose Pneumococcal Conjugate Vaccination IMMUNISATIONS You may want to know if your child should have routine immunisations and whether there could be an increased risk of complications because of the heart condition. We have sought the opinions

More information

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia 268 3105097 AHFS Category: 80:08 Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia DTaP Page 1 of 13 DESCRIPTION Tripedia, Diphtheria and Tetanus Toxoids and Acellular Pertussis

More information